%0 Journal Article
%T Current regulatory status in China of drugs withdrawn from the US FDA accelerated pathway: implications for regulation globally.
%A Luo X
%A Huang L
%A Du X
%A Yang Y
%A Lv X
%A Zhang X
%J Lancet Oncol
%V 25
%N 6
%D 2024 Jun
%M 38821082
%F 54.433
%R 10.1016/S1470-2045(24)00025-1